Growing infection control Crosstex International is a mid-sized global manufacturer specializing in infection control products for healthcare, with multiple manufacturing and distribution facilities. This indicates potential sales opportunities for their safety and sterilization product lines, including pouches, masks, sterilization monitoring, and antimicrobial gels across hospitals and clinics.

Domestic manufacturing strength The majority of Crosstex products are manufactured in the United States, highlighting a potential advantage in sourcing speed, regulatory alignment, and domestic supply chain reliability—areas buyers often prioritize for hospital procurement and GPO contracts.

Healthcare market fit With a focus on infection control and prevention products for multiple healthcare disciplines, Crosstex serves hospitals and health care facilities, presenting cross-sell opportunities across purchasing channels for related consumables, disposables, and monitoring products.

Growth through acquisitions Historical growth via acquisitions (e.g., SPSmedical) suggests a potential interest in strategic partnerships or channel expansion through complementary product lines, distribution agreements, or co-branding opportunities to broaden market reach.

Competitive landscape fit Operating in a market with players like Hospira, Cardinal Health, and Henry Schein, Crosstex positions as a specialized infection control manufacturer. This creates opportunities to propose value-add solutions, bundled offerings, or competitive pricing strategies to healthcare buyers seeking comprehensive infection control portfolios.